ZYDUS WELLNESS LTD.-$ - 531335 - Shareholding for the Period Ended September 30, 2020
Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here07-10-2020
07-10-2020
ZYDUS WELLNESS LTD.-$ - 531335 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhanraj P DagarDesignation :- Company Secretary and Compliance Officer07-10-2020
ZYDUS WELLNESS LTD.-$ - 531335 - Out Come Of Fund Raising Committee Meeting For Re-Purchase Of Debentures.
Out Come of Fund Raising Committee Meeting for re-purchase of Debentures.07-10-2020
Zydus Healthcare launches anti-diabetic Dapagliflozin drug at cheap prices
The company has launched its Dapagliflozin tablets in the strengths of 10 mg and 5 mg priced at 17 and 1404-10-2020
ZYDUS WELLNESS LTD.-$ - 531335 - Board Meeting Intimation for Intimation Of Board Meeting.
ZYDUS WELLNESS LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2020 ,inter alia, to consider and approve Intimation of Board Meeting.01-10-2020
Buy Zydus Wellness; target of Rs 2300: Sharekhan
Sharekhan is bullish on Zydus Wellness has recommended buy rating on the stock with a target price of Rs 2300 in its research report dated September 29, 2020.30-09-2020
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Allotment
Allotment of Equity Shares to QIPs.29-09-2020
Zydus Wellness shares up 4.3 per cent on QIP plan
Zydus Wellness has launched a QIP issue on September 23. The floor price was fixed at Rs 1,775 per share.The company's board is planning to meet again24-09-2020